Advertisement
Screener

XTL BIOPHARMACEUTICALS LTD. (XTLB) Form 6-K: Report of foreign private issuer, 2021

XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-12-16: Form 6-K; Period of report 2021-12-16; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152228-6k_xtlbiopharma.htm.
  • 2021-11-24: Form 6-K; Period of report 2021-11-24; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea151258-6k_xtlbiopharma.htm.
  • 2021-08-24: Form 6-K; Period of report 2021-06-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea146254-6k_xtlbiopharma.htm.
  • 2021-05-19: Form 6-K; Period of report 2021-05-19; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea141292-6k_xtlbiopharma.htm.
FiledFormPeriod of reportDescriptionDocument
2021-12-166-K2021-12-16REPORT OF FOREIGN PRIVATE ISSUERea152228-6k_xtlbiopharma.htm
2021-11-246-K2021-11-24REPORT OF FOREIGN PRIVATE ISSUERea151258-6k_xtlbiopharma.htm
2021-08-246-K2021-06-30REPORT OF FOREIGN PRIVATE ISSUERea146254-6k_xtlbiopharma.htm
2021-05-196-K2021-05-19REPORT OF FOREIGN PRIVATE ISSUERea141292-6k_xtlbiopharma.htm
2021-05-196-K2021-05-19REPORT OF FOREIGN PRIVATE ISSUERea141291-6k_xtlbiopharma.htm
2021-04-056-K2021-04-05REPORT OF FOREIGN PRIVATE ISSUERea139019-6k_xtlbiopharma.htm
2021-03-296-K2021-03-29REPORT OF FOREIGN PRIVATE ISSUERea138554-6k_xtlbiopharma.htm
2021-02-226-K2021-02-22REPORT OF FOREIGN PRIVATE ISSUERea135821-6k_xtlbiopharma.htm
2021-01-076-K2021-01-07REPORT OF FOREIGN PRIVATE ISSUERea132877-6k_xtlbiopharma.htm